0
contact-banner

Mavorixafor

Mavorixafor

API0233126

Mavorixafor

Mavacamten is used for obstructive hypertrophic cardiomyopathy.

Inquiry
API Description
API Details
Document
Related Patent Status
  • CAS No.

    558447-26-0

  • Synonyms

    558447-26-0; AMD-070; Mavorixafor

  • CHEMBL ID

    CHEMBL518924

  • Molecule Type

    Small molecule

  • Compound CID

    11256587

  • Molecular Weight (g/mol)

    349.5

  • Molecular Formula

    C21H27N5

  • InChI

    InChI=1S/C21H27N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25)/t19-/m0/s1

  • InChIKey

    WVLHHLRVNDMIAR-IBGZPJMESA-N

  • SMILES

    C1C[C@@H](C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3

  • IUPAC Name

    N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine

  • Exact Mass (Da)

    349.22664588

  • Monoisotopic Mass (Da)

    349.22664588

OUR PRODUCTS

  • API0232849

    Panobinostat Lactate

    Panobinostat Lactate

    960055-56-5

    Learn More
  • API0232137

    Bupropion Hydrobromide

    Bupropion Hydrobromide

    905818-69-1

    Learn More
  • API0231576

    Desvenlafaxine

    Desvenlafaxine

    93413-62-8

    Learn More
  • API0232500

    Levamisole Hydrochloride

    Levamisole Hydrochloride

    16595-80-5

    Learn More